[2] Genetic approaches designed to minimize cytotoxicity of retroviral protease
- 1 January 1994
- book chapter
- Published by Elsevier
- Vol. 241, 16-29
- https://doi.org/10.1016/0076-6879(94)41056-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Studies on transformation of Escherichia coli with plasmidsPublished by Elsevier ,2006
- Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genesPublished by Elsevier ,2004
- Expression of an autoprocessing cat-HIV-1 proteinase fusion protein: Purification to homogeneity of the released 99 residue proteinaseBiochemical and Biophysical Research Communications, 1991
- Strategies to Inhibit Viral Polyprotein CleavagesAnnals of the New York Academy of Sciences, 1990
- Human immunodeficiency viral protease is catalytically active as a fusion protein: Characterization of the fusion and native enzymes produced in Escherichia coliArchives of Biochemistry and Biophysics, 1990
- High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodiesGene, 1990
- Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 ProteaseScience, 1989
- High-level expression of self-processed HIV-1 protease in Escherichia coli using a synthetic geneBiochemical and Biophysical Research Communications, 1989
- Bacterial Resistance to β-Lactam Antibiotics: Crystal Structure of β-Lactamase from Staphylococcus aureus PC1 at 2.5 Å ResolutionScience, 1987
- Vectors for selective expression of cloned DNAs by T7 RNA polymeraseGene, 1987